Table 2.
List of select processes identified by KEGGa and GO analysis in 24 weeks old mutant mice and human myectomy tissue.
| R403Q-MyHC mouse heart | p value | R92W-TnT mouse | p value | Human myectomy tissue | p value |
|---|---|---|---|---|---|
| KEGG | |||||
| Endocrine and other factor-regulated calcium reabsorption | 0.003 | Val, Leu, Ile degradation | 5.8E−6 | Phagosome | 3E−11 |
| Pyruvate metabolism | 0.01 | Propanoate metabolism | 0.001 | Val, Leu, Ile degradation | 9E−7 |
| Glycerolipid metabolism | 0.03 | Fatty acid degradation | 0.004 | ||
| N-Glycan biosynthesis | 0.03 | Pantothenate and CoA biosynthesis | 0.006 | Viral myocarditis | 2E−5 |
| Regulation of lipolysis in adipocytes | 0.047 | Insulin signaling pathway | 0.01 | Carbon metabolism | 0.0002 |
| Pyruvate metabolism | 0.02 | Apoptosis | 0.0006 | ||
| Cellular senescence | 0.03 | Propanoate metabolism | 0.0006 | ||
| Fatty acid metabolism | 0.04 | HIF-1 signaling pathway | 0.0007 | ||
| Phosphatidylinositol signaling system | 0.04 | Insulin resistance | 0.001 | ||
| Insulin resistance | 0.048 | Pyruvate metabolism | 0.002 | ||
| GO cellular component | |||||
| Intrinsic component of organelle membrane | 0.01 | Mitochondrial matrix | 3.4E−9 | Contractile fiber | 1.8E−9 |
| Polysome | 0.04 | Oxidoreductase complex | 4.8E−5 | Cell-substrate junction | 4.5E−9 |
| Mitochondrial protein complex | 5.3E−5 | Mitochondrial substrate | 3.1E−5 | ||
| Organelle inner membrane | 0.001 | Actin cytoskeleton | 7.2E−5 | ||
| Mitochondrial membrane part | 0.02 | ATPase complex | 0.03 | ||
| NADH dehydrogenase complex | 0.04 | Mitochondrial inner membrane | 0.03 | ||
| GO molecular function | |||||
| ADP binding | 0.006 | Coenzyme binding | 1.9E−4 | Cofactor binding | 4.1E−7 |
| Single stranding DNA binding | 0.01 | Oxidoreductase activity on the CH-CH group of donors | 0.0010 | Cell adhesion molecule binding | 1.5E−5 |
| Basal transcription machinery binding | 0.03 | Electron transfer activity | 0.002 | Sulfur compound binding | 1.5E−5 |
| RNA polymerase II transcription factor binding | 0.03 | Oxidoreductase activity on the aldehyde or oxo group of donors | 0.003 | Oxidoreductase activity | 1.9E−5 |
| Ribonucleoprotein complex binding | 0.04 | Sulfur compound binding | 0.004 | Collagen binding | 0.0001 |
| Carboxylic ester hydrolase activity | 0.04 | Lipase activity | 0.007 | Electron carrier activity | 0.0002 |
| Catalytic activity acting on DNA | 0.04 | Carboxylic ester hydrolase activity | 0.02 | Oxidoreductase activity on CH-CH donors | 0.0003 |
| GO biologic process | |||||
| Neutral lipid metabolic process | 3.9E−4 | Fatty acid metabolic process | 2.7E−6 | Blood vessel morphogenesis | 2.3E−9 |
| Cell redox homeostasis | 0.002 | Small molecule catabolic process | 1.2E−5 | Negative regulation of growth | 1.6E−8 |
| Regulation of binding | 0.005 | Lipid modification | 1.7E−5 | Response to inorganic substance | 4.4E−8 |
| Glycerolipid metabolic process | 0.006 | Generation of precursors metabolites and energy | 2.5E−5 | Cofactor metabolic process | 4.5E−8 |
| DNA-templated transcription termination | 0.008 | Lipid catabolic process | 1.6E−4 | Actomyosin structure organization | 8E−8 |
| Response to temperature stimulus | 0.01 | Nucleoside biphosphate metabolic process | 4.8E−4 | Cellular metal ion homeostasis | 1.2E−7 |
| Cellular amino acid metabolic process | 0.002 | Regulation of vasculature development | 1.9E−7 | ||
| Organophosphate biosynthetic process | 0.004 | Plasma membrane organization | 2E−7 | ||